These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2391073)
21. The mechanism of hepatoprotection by epsilon aminocaproic acid and putrescine. Putnam CW; Buckley AR; Warneke JA; Karrer FM; Rhenman B; Steinbronn K Surgery; 1984 Aug; 96(2):214-22. PubMed ID: 6431622 [TBL] [Abstract][Full Text] [Related]
22. Antihepatotoxic activity of a quantified Desmodium adscendens decoction and D-pinitol against chemically-induced liver damage in rats. Magielse J; Arcoraci T; Breynaert A; van Dooren I; Kanyanga C; Fransen E; Van Hoof V; Vlietinck A; Apers S; Pieters L; Hermans N J Ethnopharmacol; 2013 Mar; 146(1):250-6. PubMed ID: 23291573 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of increases in ornithine decarboxylase and putrescine has no effect on rat liver regeneration. Beyer HS; Ellefson M; Stanley M; Zieve L Am J Physiol; 1992 Apr; 262(4 Pt 1):G677-84. PubMed ID: 1566849 [TBL] [Abstract][Full Text] [Related]
24. Effects of regenerating liver cytosol on drug-induced hepatic failure. Ohkawa M; Hayashi H; Chaudry IH; Clemens MG; Baue AE Surgery; 1985 Apr; 97(4):455-62. PubMed ID: 3983821 [TBL] [Abstract][Full Text] [Related]
25. Hepatobiliary clearance of labelled mebrofenin in normal and D-galactosamine HCl-induced hepatitis rats and the protective effect of turmeric extract. Deshpande UR; Joseph LJ; Samuel AM Indian J Physiol Pharmacol; 2003 Jul; 47(3):332-6. PubMed ID: 14723320 [TBL] [Abstract][Full Text] [Related]
26. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration. Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018 [TBL] [Abstract][Full Text] [Related]
27. D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? Saracyn M; Zdanowski R; Brytan M; Kade G; Nowak Z; Patera J; Dyrla P; Gil J; WaĆkowicz Z Med Sci Monit; 2015 May; 21():1469-77. PubMed ID: 26009004 [TBL] [Abstract][Full Text] [Related]
28. [Effect of putrescine on experimental acute hepatic injury in rats]. Wu XM; Zhang BG; Zhou Q; Li BR Yao Xue Xue Bao; 1988 Mar; 23(3):161-7. PubMed ID: 3421104 [No Abstract] [Full Text] [Related]
29. Effect of pretreatment of rats with uracil on liver injuries induced by D-galactosamine and allyl alcohol. Kitajima S; Ogawa N; Ariyoshi T Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):14-20. PubMed ID: 7953190 [TBL] [Abstract][Full Text] [Related]
30. Alanine protects liver from injury caused by F-galactosamine and CCl4. Maezono K; Kajiwara K; Mawatari K; Shinkai A; Torii K; Maki T Hepatology; 1996 Jul; 24(1):185-91. PubMed ID: 8707260 [TBL] [Abstract][Full Text] [Related]
31. Effects of single ethanol administration on hepatic ornithine decarboxylase induction and polyamine metabolism. Tanaka T; Nishiguchi S; Kuroki T; Kobayashi K; Matsui-Yuasa I; Otani S; Toda T; Monna T; Sukegawa Y Hepatology; 1991 Oct; 14(4 Pt 1):696-700. PubMed ID: 1916673 [TBL] [Abstract][Full Text] [Related]
32. Effect of D-galactosamine on blood clearance of 99mTc-phytate in rats. Shibata H; Hisano T J Toxicol Sci; 1989 Aug; 14(3):205-13. PubMed ID: 2810402 [TBL] [Abstract][Full Text] [Related]
34. Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice. Okano J; Shiota G; Kawasaki H Hepatology; 1997 Nov; 26(5):1241-9. PubMed ID: 9362368 [TBL] [Abstract][Full Text] [Related]
35. Insulin and glucagon therapy of acute hepatic failure. Fujiwara K; Ogata I; Sato Y; Tomiya T; Ohta Y; Oka Y; Nagoshi S; Yamada S; Masaki N; Takatsuki K Dig Dis Sci; 1991 Jun; 36(6):809-15. PubMed ID: 2032521 [TBL] [Abstract][Full Text] [Related]
36. Effects of Salmonella infection on hepatic damage following acute liver injury in rats. Li YT; Yu CB; Yan D; Huang JR; Li LJ Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):399-405. PubMed ID: 27498580 [TBL] [Abstract][Full Text] [Related]
37. Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration. Record CO; Alberti KG; Williamson DH Biochem J; 1972 Nov; 130(1):37-44. PubMed ID: 4655444 [TBL] [Abstract][Full Text] [Related]
38. Essential role of polyamine metabolism in hepatic regeneration. Inhibition of deoxyribonucleic acid and protein synthesis and tissue regeneration by difluoromethylornithine in the rat. Luk GD Gastroenterology; 1986 May; 90(5 Pt 1):1261-7. PubMed ID: 3082705 [TBL] [Abstract][Full Text] [Related]
39. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979 [TBL] [Abstract][Full Text] [Related]
40. [Cyclic AMP- and ATP-mediated stimulation of DNA synthesis following partial hepatectomy by prostaglandin-E1 in D-galactosamine injured liver]. Shimura T; Miyazaki M; Koshikawa H; Takahashi O; Sugasawa H; Fujimoto S; Okui K Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1618-24. PubMed ID: 3003557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]